# Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus

> **NCT01888796** · PHASE3 · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 8 (actual)

## Conditions studied

- Diabetes Mellitus Type 2 (T2DM)
- Left Ventricular Diastolic Dysfunction

## Interventions

- **DRUG:** Linagliptin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01888796
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** bad recruitment of suitable participants, just 8 patients in one year
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01888796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01888796, "Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01888796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*